Ignite Creation Date:
2024-05-05 @ 11:36 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00090090
Status:
COMPLETED
Last Update Posted:
2008-01-15
First Post:
2004-08-24
Brief Title:
Elsamitrucin SPI 28090 for Relapsed or Refractory Non-Hodgkins Lymphoma
Sponsor:
Organization:
Spectrum Pharmaceuticals Inc